New Delhi: India is increasingly becoming a global destination for affordable and quality healthcare, with medical tourism playing a key role in attracting patients from across the world. From complex surgeries to fertility treatments, many international patients are  with Western countries.

Against this backdrop, the Fortis Bloom IVF Centre at Fortis LaFemme Hospital in Greater Kailash-II, New Delhi, has been honoured with the FICCI Medical Value Travel Award for IVF and Reproductive Medicine at the Advantage Healthcare India 2026.

The award recognises the centre’s work in providing advanced fertility care and helping couples struggling with infertility. The honour also highlights the long-standing contribution of fertility specialists Hrishikesh Pai and Nandita Palshetkar, medical directors of the Bloom IVF Group, who together bring more than 40 years of experience in reproductive medicine.

The award was presented by Union Minister Sh. Gajendra Singh Shekhawat. It was received by Ojaswini Kapoor, CEO of Bloom IVF Group, along with Garima Prasad, Facility Director of Fortis LaFemme Hospital.

Dr Hrishikesh said medical tourism is playing an important role in strengthening India’s global healthcare image. “Medical tourism is playing an increasingly important role in positioning India as a global hub for quality and affordable healthcare. Patients from countries such as the United States, Canada, the Middle East, Africa, Europe, Australia and New Zealand come to India for fertility treatment,” he said.

Bloom IVF Group currently operates centres at Lilavati Hospital in Mumbai, DY Patil Hospital in Navi Mumbai, Fortis LaFemme Hospital in Delhi, Medsovis Hospital in Gurugram and Fortis Hospital in Mohali.

Dr Nandita said the group remains committed to providing advanced fertility treatment with high success rates at affordable costs. The centres are equipped with modern embryology laboratories, and supported by trained IVF specialists, she said.